Silvercrest Asset Management Group 13F: Cuts ADUS Stake by $6.4M

Silvercrest Asset Management Group has trimmed its stake in Addus HomeCare Corporation (NasdaqGS: ADUS), according to its latest 13F filing with the SEC. As of the reporting period, the firm reduced its holdings by 65,501 shares, bringing its total to 729,196 shares valued at approximately $68 million. This represents an 8.24% decrease from its previous position.

What Changed in Silvercrest's Addus HomeCare Position

Silvercrest's decision to cut its stake in Addus HomeCare saw its holdings drop from 794,697 shares to 729,196 shares. This reduction of 65,501 shares reflects an 8.24% decrease in its investment, now valued at about $68 million. The move is part of the firm's latest filing for the quarter.

Other Institutional Activity in Addus HomeCare

Other major funds have also adjusted their positions in Addus HomeCare. BlackRock, Inc. increased its holdings by 281,200 shares to a total of 3,090,230 shares, valued at approximately $289.4 million. Meanwhile, Capital Research Global Investors added 65,572 shares, raising its stake to 1,535,324 shares worth about $143.8 million. On the other hand, Wasatch Advisors LP reduced its position by 39,676 shares, bringing its total to 867,825 shares valued at $81.3 million. Dimensional Fund Advisors LP increased its holdings by 78,415 shares, resulting in a total of 744,127 shares worth $69.7 million.

Addus HomeCare Corporation Stock Down 16.2%

Shares of Addus HomeCare Corporation traded at $93.28. The company has a market cap of $1.74 billion and a P/E ratio of 17.2. Its forward P/E is 12.5, indicating expectations of future earnings growth. The stock's 52-week range is between $87.95 and $124.44. Addus HomeCare's 50-day moving average is $94.04, while its 200-day moving average is $106.66. The company's current ratio stands at 1.83, with a quick ratio of 1.68 and a debt-to-equity ratio of 12.43.

Recent Earnings

Addus HomeCare reported revenue of approximately $1.45 billion, reflecting a growth rate of 7.7%. The company's net margin is 6.89%, with a return on equity of 9.45%. Earnings per share stand at $5.42. The next earnings release is scheduled for August 3, 2026.

Insider Buying and Selling at Addus HomeCare Corporation

On June 10, several insiders, including Jean Rush, Darin Gordon, and Veronica Hill-Milbourne, each purchased 1,449 shares. These transactions were not planned under Rule 10b5-1.

Analysts Set New Price Targets

Analysts have set varied price targets for Addus HomeCare. On May 15, Barclays maintained a sell rating with a $92 target. Earlier, on May 6, Citizens maintained a buy rating with a target of $142. The consensus target price among analysts is approximately $132.69, with 13 analysts offering opinions.

About Addus HomeCare

Addus HomeCare Corporation provides personal care services to elderly, chronically ill, and disabled individuals in the U.S., aiming to prevent hospitalization or institutionalization. The company operates through segments such as Personal Care, Hospice, and Home Health. Founded in 1979 and headquartered in Frisco, Texas, Addus HomeCare employs around 5,982 people.

Bottom Line

Silvercrest Asset Management's trimming of its Addus HomeCare position is part of its latest quarterly adjustments. Investors follow such filings to understand institutional sentiment, though it's important to note these 13F filings reflect past positions and may not represent current holdings. Addus HomeCare continues to attract attention with its stable financial performance and insider buying activity.